The biochemistry analyzer market size has grown strongly in recent years. It will grow from $4.04 billion in 2023 to $4.31 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth during the historic period can be attributed to factors such as the increased incidence of chronic diseases, expansion of healthcare infrastructure, rising research and development activities, a high demand for diagnostic accuracy, an aging population, and supportive government initiatives.
The biochemistry analyzer market size is expected to see strong growth in the next few years. It will grow to $5.63 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth during the forecast period can be attributed to the rise of personalized medicine, expansion in emerging markets, advancements in analytical techniques, a growing focus on preventive healthcare, the integration of AI and machine learning, increased investment in research, and a demand for cost-effective solutions. Key trends expected to drive growth include technological integration, miniaturization and portability of devices, enhanced automation, personalized diagnostics, integration with healthcare IT systems, increased use of molecular diagnostics, and a focus on sustainability.
The biochemistry analyzer market is expected to grow due to the rising incidence of cardiovascular disorders. Cardiovascular diseases encompass various conditions affecting the heart and blood vessels, including complications such as heart attack, stroke, and peripheral artery disease (PAD). The prevalence of these conditions is increasing due to factors such as an aging population, sedentary lifestyles, poor dietary habits, and high obesity rates. Biochemistry analyzers play a crucial role in diagnosing and managing cardiovascular disorders by providing accurate and timely measurements of key biomarkers. This helps healthcare professionals monitor patient health, assess risk factors, and customize treatment plans. For example, in January 2024, the American Heart Association reported that cardiovascular disease-related deaths in the US increased to 931,578 from 928,741 in 2023. Additionally, the age-adjusted death rate for cardiovascular diseases rose to 233.3 per 100,000 in 2024, a 4% increase from 224.4 per 100,000 in 2023. This rising incidence of cardiovascular disorders is fueling the growth of the biochemistry analyzer market.
Leading companies in the biochemistry analyzer market are focusing on developing advanced immunoassay analyzer platforms to improve diagnostic accuracy and reduce maintenance needs. These platforms use immunoassay techniques to measure specific biomarkers in biological samples, offering high accuracy and sensitivity for detecting various conditions, thus enhancing diagnostic efficiency and patient care. For instance, in May 2023, Beckman Coulter Inc., a US-based clinical diagnostics firm, introduced the DxI 9000 Access Immunoassay Analyzer. This state-of-the-art platform can perform up to 215 tests per hour per square meter and includes advanced features such as PrecisionVision Technology for real-time data accuracy, ZeroDaily Maintenance to minimize upkeep, and IntelliServe for proactive remote service and diagnostics. The DxI 9000 also supports rapid and precise heart failure diagnosis through its NT-proBNP assay and enhances assay sensitivity with the Lumi-Phos PRO Substrate, catering to the growing demand for speed, reliability, and precision in clinical laboratories.
In July 2021, DiaSorin SpA, an Italy-based biotechnology company, acquired Luminex Corporation for $1.8 billion. This acquisition aims to expand DiaSorin’s product range and strengthen its collaboration with biopharmaceutical companies, fostering long-term partnerships. Luminex Corporation, based in the US, specializes in biological testing technologies, including biochemistry and flow cytometry analyzers.
Major companies operating in the biochemistry analyzer market are Roche Holding AG, Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Agilent Technologies, Mindray Bio-Medical Electronics Co. Ltd., Hologic Inc., Hitachi High-Technologies Corporation, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics, Horiba Medical Ltd, Randox Laboratories Ltd., NOVA Biomedical Corp., Tecom Group, Dirui Industries Co. Ltd., Transasia Biomedicals Ltd., ELITechGroup, Medison Pharma, NantHealth Inc., Awareness Technology Inc., Rayto Life and Analytical Sciences Co. Ltd., DPC (Diagnostic Products Corporation), Cypress Diagnostics Inc, Urit Medical Electronic Group, Adaltis Inc.
Europe was the largest region in the biochemistry analyzer market in 2023. The regions covered in the biochemistry analyzer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the biochemistry analyzer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A biochemistry analyzer is a medical laboratory instrument designed to measure the concentration of various biochemical substances in biological samples. It performs tests to analyze enzymes, electrolytes, proteins, and other biochemical compounds by conducting chemical reactions and providing quick, accurate results.
The primary types of biochemistry analyzers are semi-automated and fully-automated. A semi-automated biochemistry analyzer is a device that requires some manual intervention for tasks such as sample preparation or reagent handling but automates the testing process. These analyzers come in different modalities, including bench-top and floor-standing models. They are used in various applications such as clinical diagnostics, bioreactor byproduct detection, and drug development. End users include hospitals, diagnostic centers, pharmaceutical companies, biotechnology firms, academic research institutes, and contract research organizations.
The biochemistry analyzer market research report is one of a series of new reports that provides biochemistry analyzer market statistics, including biochemistry analyzer industry global market size, regional shares, competitors with an biochemistry analyzer market share, detailed biochemistry analyzer market segments, market trends and opportunities, and any further data you may need to thrive in the biochemistry analyzer industry. This biochemistry analyzer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A biochemistry analyzer market consists of sales of reagent kits, control and calibration solutions, software for data management, and consumables to support the operation and performance of the analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The biochemistry analyzer market size is expected to see strong growth in the next few years. It will grow to $5.63 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth during the forecast period can be attributed to the rise of personalized medicine, expansion in emerging markets, advancements in analytical techniques, a growing focus on preventive healthcare, the integration of AI and machine learning, increased investment in research, and a demand for cost-effective solutions. Key trends expected to drive growth include technological integration, miniaturization and portability of devices, enhanced automation, personalized diagnostics, integration with healthcare IT systems, increased use of molecular diagnostics, and a focus on sustainability.
The biochemistry analyzer market is expected to grow due to the rising incidence of cardiovascular disorders. Cardiovascular diseases encompass various conditions affecting the heart and blood vessels, including complications such as heart attack, stroke, and peripheral artery disease (PAD). The prevalence of these conditions is increasing due to factors such as an aging population, sedentary lifestyles, poor dietary habits, and high obesity rates. Biochemistry analyzers play a crucial role in diagnosing and managing cardiovascular disorders by providing accurate and timely measurements of key biomarkers. This helps healthcare professionals monitor patient health, assess risk factors, and customize treatment plans. For example, in January 2024, the American Heart Association reported that cardiovascular disease-related deaths in the US increased to 931,578 from 928,741 in 2023. Additionally, the age-adjusted death rate for cardiovascular diseases rose to 233.3 per 100,000 in 2024, a 4% increase from 224.4 per 100,000 in 2023. This rising incidence of cardiovascular disorders is fueling the growth of the biochemistry analyzer market.
Leading companies in the biochemistry analyzer market are focusing on developing advanced immunoassay analyzer platforms to improve diagnostic accuracy and reduce maintenance needs. These platforms use immunoassay techniques to measure specific biomarkers in biological samples, offering high accuracy and sensitivity for detecting various conditions, thus enhancing diagnostic efficiency and patient care. For instance, in May 2023, Beckman Coulter Inc., a US-based clinical diagnostics firm, introduced the DxI 9000 Access Immunoassay Analyzer. This state-of-the-art platform can perform up to 215 tests per hour per square meter and includes advanced features such as PrecisionVision Technology for real-time data accuracy, ZeroDaily Maintenance to minimize upkeep, and IntelliServe for proactive remote service and diagnostics. The DxI 9000 also supports rapid and precise heart failure diagnosis through its NT-proBNP assay and enhances assay sensitivity with the Lumi-Phos PRO Substrate, catering to the growing demand for speed, reliability, and precision in clinical laboratories.
In July 2021, DiaSorin SpA, an Italy-based biotechnology company, acquired Luminex Corporation for $1.8 billion. This acquisition aims to expand DiaSorin’s product range and strengthen its collaboration with biopharmaceutical companies, fostering long-term partnerships. Luminex Corporation, based in the US, specializes in biological testing technologies, including biochemistry and flow cytometry analyzers.
Major companies operating in the biochemistry analyzer market are Roche Holding AG, Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Agilent Technologies, Mindray Bio-Medical Electronics Co. Ltd., Hologic Inc., Hitachi High-Technologies Corporation, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics, Horiba Medical Ltd, Randox Laboratories Ltd., NOVA Biomedical Corp., Tecom Group, Dirui Industries Co. Ltd., Transasia Biomedicals Ltd., ELITechGroup, Medison Pharma, NantHealth Inc., Awareness Technology Inc., Rayto Life and Analytical Sciences Co. Ltd., DPC (Diagnostic Products Corporation), Cypress Diagnostics Inc, Urit Medical Electronic Group, Adaltis Inc.
Europe was the largest region in the biochemistry analyzer market in 2023. The regions covered in the biochemistry analyzer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the biochemistry analyzer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A biochemistry analyzer is a medical laboratory instrument designed to measure the concentration of various biochemical substances in biological samples. It performs tests to analyze enzymes, electrolytes, proteins, and other biochemical compounds by conducting chemical reactions and providing quick, accurate results.
The primary types of biochemistry analyzers are semi-automated and fully-automated. A semi-automated biochemistry analyzer is a device that requires some manual intervention for tasks such as sample preparation or reagent handling but automates the testing process. These analyzers come in different modalities, including bench-top and floor-standing models. They are used in various applications such as clinical diagnostics, bioreactor byproduct detection, and drug development. End users include hospitals, diagnostic centers, pharmaceutical companies, biotechnology firms, academic research institutes, and contract research organizations.
The biochemistry analyzer market research report is one of a series of new reports that provides biochemistry analyzer market statistics, including biochemistry analyzer industry global market size, regional shares, competitors with an biochemistry analyzer market share, detailed biochemistry analyzer market segments, market trends and opportunities, and any further data you may need to thrive in the biochemistry analyzer industry. This biochemistry analyzer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A biochemistry analyzer market consists of sales of reagent kits, control and calibration solutions, software for data management, and consumables to support the operation and performance of the analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Biochemistry Analyzer Market Characteristics3. Biochemistry Analyzer Market Trends and Strategies32. Global Biochemistry Analyzer Market Competitive Benchmarking33. Global Biochemistry Analyzer Market Competitive Dashboard34. Key Mergers and Acquisitions in the Biochemistry Analyzer Market
4. Biochemistry Analyzer Market - Macro Economic Scenario
5. Global Biochemistry Analyzer Market Size and Growth
6. Biochemistry Analyzer Market Segmentation
7. Biochemistry Analyzer Market Regional and Country Analysis
8. Asia-Pacific Biochemistry Analyzer Market
9. China Biochemistry Analyzer Market
10. India Biochemistry Analyzer Market
11. Japan Biochemistry Analyzer Market
12. Australia Biochemistry Analyzer Market
13. Indonesia Biochemistry Analyzer Market
14. South Korea Biochemistry Analyzer Market
15. Western Europe Biochemistry Analyzer Market
16. UK Biochemistry Analyzer Market
17. Germany Biochemistry Analyzer Market
18. France Biochemistry Analyzer Market
19. Italy Biochemistry Analyzer Market
20. Spain Biochemistry Analyzer Market
21. Eastern Europe Biochemistry Analyzer Market
22. Russia Biochemistry Analyzer Market
23. North America Biochemistry Analyzer Market
24. USA Biochemistry Analyzer Market
25. Canada Biochemistry Analyzer Market
26. South America Biochemistry Analyzer Market
27. Brazil Biochemistry Analyzer Market
28. Middle East Biochemistry Analyzer Market
29. Africa Biochemistry Analyzer Market
30. Biochemistry Analyzer Market Competitive Landscape and Company Profiles
31. Biochemistry Analyzer Market Other Major and Innovative Companies
35. Biochemistry Analyzer Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Biochemistry Analyzer Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on biochemistry analyzer market which is experiencing strong growth. the report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biochemistry analyzer? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biochemistry analyzer market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- the impact of higher inflation in many countries and the resulting spike in interest rates.
- the continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Product Type: Semi-Automated; Fully-Automated2) by Modality: Bench Top; Floor-Standing
3) by Application: Clinical Diagnostics; Bioreactor Byproduct Detection; Drug Development; Other Application
4) by End User: Hospitals; Diagnostic Centers; Pharmaceutical Companies; Biotechnology Companies; Academic Research Institutes; Contract Research Organizations
Key Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific; Abbott Laboratories; Siemens Healthineers; Agilent Technologies
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Roche Holding AG
- Thermo Fisher Scientific
- Abbott Laboratories
- Siemens Healthineers
- Agilent Technologies
- Mindray Bio-Medical Electronics Co. Ltd.
- Hologic Inc.
- Hitachi High-Technologies Corporation
- Beckman Coulter Inc.
- Sysmex Corporation
- Bio-Rad Laboratories Inc
- Ortho Clinical Diagnostics
- Horiba Medical Ltd
- Randox Laboratories Ltd.
- NOVA Biomedical Corp.
- Tecom Group
- Dirui Industries Co. Ltd.
- Transasia Biomedicals Ltd.
- ELITechGroup
- Medison Pharma
- NantHealth Inc.
- Awareness Technology Inc.
- Rayto Life and Analytical Sciences Co. Ltd.
- DPC (Diagnostic Products Corporation)
- Cypress Diagnostics Inc
- Urit Medical Electronic Group
- Adaltis Inc
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | September 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 4.31 Billion |
Forecasted Market Value ( USD | $ 5.63 Billion |
Compound Annual Growth Rate | 6.9% |
Regions Covered | Global |
No. of Companies Mentioned | 27 |